Please provide your email address to receive an email when new articles are posted on . The FDA removed a warning about CV risk from testosterone product labels after a randomized trial showed no link ...

The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies. The ...

The TRAVERSE trial showed testosterone replacement treatment was noninferior to placebo with regard to the risk of major adverse cardiac events. The Food and Drug Administration (FDA) is requiring ...

The FDA announced Tuesday that it is increasing warnings against testosterone and other steroids, NBC News reported. In addition to existing concerns about personality changes and other health issues, ...

The Androgen Society concluded that testosterone therapy does not increase risk for major cardiovascular events. Despite Food and Drug Administration (FDA) warning label requirements, testosterone ...

Lauren Pastrana is the co-anchor of CBS4 News weeknights at 5, 6, 7 and 11 p.m. She joined CBS Miami in April 2012 as a reporter. She is an Emmy-nominated, multimedia journalist with experience in ...

Testosterone and hormonal balance in men are often overlooked. Research shows men face an earlier, subtle decline, causing fatigue, low mood, and muscle loss. Modern lifestyles may worsen it.

June 20 (Reuters) - The U.S. Food and Drug Administration said all testosterone products on the market should include in their labels a general warning about the risk of blood clots in veins. The ...

Testosterone is popularly known as the male hormone. This hormone turns a boy into a man; causes hair to sprout on chest and face and deepens the voice among a host of other physical and mental ...